文献速递乳房整形与再造美容整形

经腋窝乳房增大术中乳头保护罩的应用研究

Nipple Shields in Transaxillary Breast Augmentation.
PubMed 文献 · Ann Plast Surg · 2017-01-01

该研究评估经腋窝乳房增大术中乳头保护罩能否减少假体污染,对26例患者保护罩下分泌物培养并随访18个月,另回顾753例2008–2012年乳房增大术感染率。结果显示保护罩下13.5%乳房培养阳性,研究组无感染或包膜挛缩,回顾组急性感染0.26%、迟发感染0.66%。结论认为经腋窝途径使用乳头保护罩对结局无差异。

要点

  • 经腋窝乳房增大术中,乳头保护罩下13.5%乳房培养阳性,但研究组无感染或包膜挛缩。
  • 回顾753例乳房增大术,急性感染0.26%、迟发感染0.66%,急性感染由金黄色葡萄球菌引起。
  • 迟发感染中3例分离出铜绿假单胞菌、1例金黄色葡萄球菌,所有病例存在感染背景。

核心结论

  • 经腋窝乳房增大术中使用乳头保护罩对结局无差异。
  • 急性感染更可能经乳晕途径发生,迟发感染可能有血源性成分。

研究设计与样本

  • 对26例经腋窝切口患者取保护罩敷料培养并随访18个月。
  • 回顾2008–2012年753例乳房增大术患者,年龄18–62岁,平均34岁。
  • 753例中72.5%采用经腋窝切口,59.2%置于筋膜下,78%使用解剖型假体。

主要发现

  • 研究组无感染或包膜挛缩病例。
  • 13.5%乳房保护罩下拭子培养阳性,分离出表皮葡萄球菌和粪肠球菌。
  • 回顾组急性感染2例(0.26%),由金黄色葡萄球菌引起。
  • 回顾组迟发感染5例(0.66%),3例分离出铜绿假单胞菌、1例金黄色葡萄球菌。

临床怎么用

  • 经腋窝乳房增大术中乳头保护罩未能改变感染或包膜挛缩结局。
  • 需关注乳晕途径相关急性感染及迟发感染的血源性可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infection after breast augmentation occurs in 1.1% to 2.5% of patients. Bacterial contamination of the implants could explain some complications of breast implant surgery, including infection, capsular contracture and even anaplastic large cell lymphoma. Because of the evidence of bacterial spread from the nipple, nipple shields have been proposed as a routine maneuver to avoid contamination of the implants. OBJECTIVE: To determine if nipple shields are useful in transaxillary breast augmentation. METHODS: A culture was obtained from the dressing (nipple shield) in 26 patients with transaxillary incision, and follow-up lasted for 18 months. A retrospective study of patients undergoing breast augmentation between 2008 and 2012 was conducted as well to know our rate of infections. A total of 753 patients between the ages of 18 and 62 years, with a mean age of 34 years, were identified. Of these 753 patients, most underwent surgery using a transaxillary incision (72.5%). The most common placement plane was subfascial (59.2%), and in most cases, an anatomical prosthesis (78%) was used. RESULTS: No cases of infection or capsular contracture were observed in the study group. However, 13.5% of the breasts had positive cultures of swabs taken under the nipple shields. Staphylococcus epidermidis and Enterococcus faecalis were isolated from the nipple culture. Within the retrospective study, we detected 2 cases of acute infection (0.26%) and 5 cases of late infection (0.66%). The acute infections were caused by Staphylococcus aureus. In the late infections, Pseudomonas aeruginosa was isolated in 3 cases, and S. aureus was isolated in 1 case. CONCLUSIONS: Nipple shields did not make any difference for outcomes when using the transaxillary method. Acute infections seem to occur more frequently via the areola route. Late infections seem to have a hematogenous component because an infectious background was present in all cases.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Benito-Ruiz J. Nipple Shields in Transaxillary Breast Augmentation. Ann Plast Surg. 2017. PMID: 28166134. doi:10.1097/SAP.0000000000000895

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。